Request Demo
Last update 26 Oct 2025
Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Last update 26 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Amlodipine/atorvastatin/valsartan, Atorvastatin/amlodipine/valsartan, Valsartan/atorvastatin/amlodipine + [2] |
Target |
Action antagonists, inhibitors, blockers |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC24H29N5O3 |
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N |
CAS Registry137862-53-4 |
View All Structures (4)
Related
2
Clinical Trials associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/ValsartanNCT03639480
A Double-blind, Randomized, Multi-center Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of CJ-30061 Compared With Amlodipine/Valsartan Combination Therapy and Valsartan/Atorvastatin Combination Therapy in Hypertensive Patients With Hyperlipidemia
NCT03657472
An Open-label, Randomized, Single-dose, 3-period Replicated Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of CJ-30061 Alone and Co-administration of Amlodipine/Valsartan and Atorvastatin in Healthy Adult Volunteers
100 Clinical Results associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Deals associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 3 | United States | 13 Oct 2017 | |
| Hypertension | Phase 3 | United States | 13 Oct 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free